Amanda Smith is counsel in the firm’s Healthcare and FDA practice with a focus
on the federal 340B drug pricing program, advising clients on regulatory,
legislative, and litigation matters related to the program. Prior to joining the
firm, Amanda was legal counsel for a not-for-profit association of hospitals and
health systems. She developed state and federal regulatory, legal, and legislative
advocacy in the areas of health policy and drug pricing, as well as provided
compliance support to the association’s respective members. She played a key
role in the development of state level policy and advocacy resources, created the
association’s grassroots advocacy program and coordinated advocacy efforts
between hospitals and Congress.
She also served as a healthcare law clerk for the United States Senate Committee on
Finance and as a United States Senate Page.
